Daniel G Meeker1, Tengjiao Wang2, Walter N Harrington3, Vladimir P Zharov3, Sarah A Johnson1, Samir V Jenkins4, Stephanie E Oyibo2, Christopher M Walker1, Weston B Mills1, Mark E Shirtliff5,6, Karen E Beenken1, Jingyi Chen2, Mark S Smeltzer1. 1. a Department of Microbiology and Immunology , University of Arkansas for Medical Sciences , Little Rock , AR , USA. 2. b Department of Chemistry and Biochemistry , University of Arkansas , Fayetteville , AR , USA. 3. c Phillips Classic Laser and Nanomedicine Laboratories , University of Arkansas for Medical Sciences , Little Rock , AR , USA. 4. d Department of Radiation Oncology , University of Arkansas for Medical Sciences , Little Rock , AR , USA. 5. e Department of Microbial Pathogenesis , Dental School, University of Maryland-Baltimore , Baltimore , MD , USA. 6. f Department of Microbiology and Immunology , School of Medicine, University of Maryland-Baltimore , Baltimore , MD , USA.
Abstract
BACKGROUND: We previously demonstrated that a photoactivatable therapeutic approach employing antibiotic-loaded, antibody-conjugated, polydopamine (PDA)-coated gold nanocages (AuNCs) could be used for the synergistic killing of bacterial cells within a biofilm. The approach was validated with a focus on Staphylococcus aureus using an antibody specific for staphylococcal protein A (Spa) and an antibiotic (daptomycin) active against Gram-positive cocci including methicillin-resistant S. aureus (MRSA). However, an important aspect of this approach is its potential therapeutic versatility. METHODS: In this report, we evaluated this versatility by examining the efficacy of AuNC formulations generated with alternative antibodies and antibiotics targeting S. aureus and alternative combinations targeting the Gram-negative pathogen Pseudomonas aeruginosa. RESULTS: The results confirmed that daptomycin-loaded AuNCs conjugated to antibodies targeting two different S. aureus lipoproteins (SACOL0486 and SACOL0688) also effectively kill MRSA in the context of a biofilm. However, our results also demonstrate that antibiotic choice is critical. Specifically, ceftaroline and vancomycin-loaded AuNCs conjugated to anti-Spa antibodies were found to exhibit reduced efficacy relative to daptomycin-loaded AuNCs conjugated to the same antibody. In contrast, gentamicin-loaded AuNCs conjugated to an antibody targeting a conserved outer membrane protein were highly effective against P. aeruginosa biofilms. CONCLUSIONS: These results confirm the therapeutic versatility of our approach. However, to the extent that its synergistic efficacy is dependent on the ability to achieve both a lethal photothermal effect and the thermally controlled release of a sufficient amount of antibiotic, they also demonstrate the importance of carefully designing appropriate antibody and antibiotic combinations to achieve the desired therapeutic synergy.
BACKGROUND: We previously demonstrated that a photoactivatable therapeutic approach employing antibiotic-loaded, antibody-conjugated, polydopamine (PDA)-coated gold nanocages (AuNCs) could be used for the synergistic killing of bacterial cells within a biofilm. The approach was validated with a focus on Staphylococcus aureus using an antibody specific for staphylococcal protein A (Spa) and an antibiotic (daptomycin) active against Gram-positive cocci including methicillin-resistant S. aureus (MRSA). However, an important aspect of this approach is its potential therapeutic versatility. METHODS: In this report, we evaluated this versatility by examining the efficacy of AuNC formulations generated with alternative antibodies and antibiotics targeting S. aureus and alternative combinations targeting the Gram-negative pathogenPseudomonas aeruginosa. RESULTS: The results confirmed that daptomycin-loaded AuNCs conjugated to antibodies targeting two different S. aureus lipoproteins (SACOL0486 and SACOL0688) also effectively kill MRSA in the context of a biofilm. However, our results also demonstrate that antibiotic choice is critical. Specifically, ceftaroline and vancomycin-loaded AuNCs conjugated to anti-Spa antibodies were found to exhibit reduced efficacy relative to daptomycin-loaded AuNCs conjugated to the same antibody. In contrast, gentamicin-loaded AuNCs conjugated to an antibody targeting a conserved outer membrane protein were highly effective against P. aeruginosa biofilms. CONCLUSIONS: These results confirm the therapeutic versatility of our approach. However, to the extent that its synergistic efficacy is dependent on the ability to achieve both a lethal photothermal effect and the thermally controlled release of a sufficient amount of antibiotic, they also demonstrate the importance of carefully designing appropriate antibody and antibiotic combinations to achieve the desired therapeutic synergy.
Authors: Daniel G Meeker; Karen E Beenken; Weston B Mills; Allister J Loughran; Horace J Spencer; William B Lynn; Mark S Smeltzer Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191
Authors: Louise Kruse Jensen; Henrik Elvang Jensen; Janne Koch; Thomas Bjarnsholt; Steffen Eickhardt; Mark Shirtliff Journal: In Vivo Date: 2015 Sep-Oct Impact factor: 2.155
Authors: Samir V Jenkins; Dmitry A Nedosekin; Emily K Miller; Vladimir P Zharov; Ruud P M Dings; Jingyi Chen; Robert J Griffin Journal: Int J Hyperthermia Date: 2017-05-09 Impact factor: 3.914
Authors: Nazar Orishchin; Cameron C Crane; Matthew Brownell; Tengjiao Wang; Samuel Jenkins; Min Zou; Arun Nair; Jingyi Chen Journal: Langmuir Date: 2017-06-06 Impact factor: 3.882
Authors: Matthew E Falagas; Ioannis A Bliziotis; Sofia K Kasiakou; George Samonis; Panayiota Athanassopoulou; Argyris Michalopoulos Journal: BMC Infect Dis Date: 2005-04-08 Impact factor: 3.090
Authors: Ekaterina I Galanzha; Evgeny Shashkov; Mustafa Sarimollaoglu; Karen E Beenken; Alexei G Basnakian; Mark E Shirtliff; Jin-Woo Kim; Mark S Smeltzer; Vladimir P Zharov Journal: PLoS One Date: 2012-09-26 Impact factor: 3.240
Authors: Joseph S Rom; Karen E Beenken; Aura M Ramirez; Christopher M Walker; Ethan J Echols; Mark S Smeltzer Journal: Virulence Date: 2021-12 Impact factor: 5.882